Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
Over the past two decades, many studies have identified significant contributions of toxic β-amyloid peptides (Aβ) to the etiology of Alzheimer’s disease (AD), which is the most common age-dependent neurodegenerative disease. AD is also recognized as a disease of synaptic failure. Aβ, generated by sequential proteolytic cleavages of amyloid precursor protein (APP) by BACE1 and γ-secretase, is one of major culprits that cause this failure. In this review, we summarize current findings on how BACE1-cleaved APP products impact learning and memory through proteins localized on glutamatergic, GABAergic, and dopaminergic synapses. Considering the broad effects of Aβ on all three types of synapses, BACE1 inhibition emerges as a practical approach for ameliorating Aβ-mediated synaptic dysfunctions. Since BACE1 inhibitory drugs are currently in clinical trials, this review also discusses potential complications arising from BACE1 inhibition. We emphasize that the benefits of BACE1 inhibitory drugs will outweigh the concerns.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
AMPA Receptor Trafficking and Synaptic Plasticity
Malinow, R., & Malenka, R. C. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142758 · Cited by 2,588 · cited 1×
“Compared to relatively stationary NMDARs, trafficking of AMPARs to dendrites and spines is a key step for the control of postsynaptic plasticity; LTP promotes recruitment of more AMPAs to postsynaptic membranes for long-lasting potentials (Malinow and Malenka, 2002).”
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Benilova, I., Karran, E., & De Strooper, B. (2012) · Nature Neuroscience · doi:10.1038/nn.3028 · Cited by 1,962 · cited 2×
“, 2009)] and the lack of patients diagnosed with amyloid plaque-only dementia (Benilova et al., 2012; Skaper, 2012), it is legitimate to question whether work on the Amyloid Cascade Hypothesis has reached an impasse.”
Plasticity during stroke recovery: from synapse to behaviour
Murphy, T. H., & Corbett, D. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2735 · Cited by 1,938 · cited 1×
“Enhanced synaptic transmission translates to stronger synaptic strength; memory formation is highly related to long-term changes in synaptic strength, which is quantifiable by electrophysiological measures (Murphy and Corbett, 2009).”
Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F. (1998) · Nature · doi:10.1038/34910 · Cited by 1,818 · cited 1×
“…et al., 1999; Lin et al., 2000; Sinha et al., 1999; Vassar et al., 1999; Yan et al., 1999). γ-secretase is a complex composed mainly of four transmembrane proteins: presenilin-1 or -2, nicastrin, Aph1, and Pen2 (De Strooper et al., 1998; Francis et al., 2002; Li et al., 2000; Yu et al., 2000).”
Dopamine neuron systems in the brain: An update
Björklund, A., & Dunnett, S. B. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.006 · Cited by 1,777 · cited 1×
“…(Ferando and Mody, 2014). iii) Dopaminergic synapses Dopaminergic synapses, formed by presynaptic axonal termini from dopaminergic neurons and dendrites from pyramidal neurons or interneurons, play a key role in protein synthesis-dependent forms of synaptic plasticity (Bjorklund and Dunnett, 2007).”
Palop, J. J., Chin, J., Roberson, E. D., Wang, J., Thwin, M. T., Bien-Ly, N., Yoo, J., Ho, K. O., Yu, G.-Q., Kreitzer, A., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.025 · Cited by 1,653 · cited 1×
“In AD PS1/APP J20 mouse dentate gyrus, aberrant overexcitation is linked to high levels of Aβ, which sensitizes at least some neuronal networks due to disrupted GABA function (Palop et al., 2007).”
Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Palop, J. J., & Mucke, L. (2010) · Nature Neuroscience · doi:10.1038/nn.2583 · Cited by 1,651 · cited 3×
“Reportedly, abnormal accumulation of Aβ in the form of dimers, trimers, or oligomers in the synaptic cleft is highly correlated with memory- related synaptic dysfunctions in AD (Haass and Selkoe, 2007; Palop and Mucke, 2010; Sheng et al., 2012).”
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644 · cited 1×
“Suppressed Aβ generation by γ secretase inhibition is sufficient to increase EPSC frequency (Kamenetz et al., 2003).”
Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592 · cited 1×
“Aβ, mainly in soluble multimers or oligomers, directly interacts with NMDARs in pathophysiological conditions (Lacor et al., 2007; Shankar et al., 2007).”
Regulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
Laurén, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., & Strittmatter, S. M. (2009) · Nature · doi:10.1038/nature07761 · Cited by 1,560
Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity
Yan, R., Bienkowski, M. J., Shuck, M. E., Miao, H., Tory, M. C., Pauley, A. M., Brashler, J. R., Stratman, N. C., Mathews, W. R., Buhl, A. E., et al. (1999) · Nature · doi:10.1038/990107 · Cited by 1,438 · cited 1×
“…known as Asp2 and memapsin 2, was discovered to be the β-secretase (Hussain et al., 1999; Lin et al., 2000; Sinha et al., 1999; Vassar et al., 1999; Yan et al., 1999). γ-secretase is a complex composed mainly of four transmembrane proteins: presenilin-1 or -2, nicastrin, Aph1, and Pen2 (De…”
Self-citationThe Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s Disease
Spires-Jones, T. L., & Hyman, B. T. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.004 · Cited by 1,201
Lacor, P. N., Buniel, M. C., Furlow, P. W., Sanz Clemente, A., Velasco, P. T., Wood, M., Viola, K. L., & Klein, W. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3501-06.2007 · Cited by 1,188 · cited 1×
“Aβ, mainly in soluble multimers or oligomers, directly interacts with NMDARs in pathophysiological conditions (Lacor et al., 2007; Shankar et al., 2007).”
NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders
Lau, C. G., & Zukin, R. S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2153 · Cited by 1,159 · cited 1×
“…AMPARs, but not NMDARs, into and out of the synaptic membrane, followed by internalization, induces long-term depression (LTD), which can in turn cause endocytosis of NMDARs, shrinkage of dendritic spines, endocytosis of AMPARs, and synapse loss (Borgdorff and Choquet, 2002; Lau and Zukin, 2007).”
Trafficking and Proteolytic Processing of APP
Haass, C., Kaether, C., Thinakaran, G., & Sisodia, S. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006270 · Cited by 1,075 · cited 2×
“ADAM10, as well as ADAM17 and ADAM9, are recognized as α-secretases and prevent Aβ formation by cleaving APP within the Aβ domain (mainly after Q16 and K17) [see reviews by (Allinson et al., 2004; Asai et al., 2003; Haass et al., 2012; Kuhn et al., 2010; Saftig and Lichtenthaler, 2015)].”
AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss
Hsieh, H., Boehm, J., Sato, C., Iwatsubo, T., Tomita, T., Sisodia, S., & Malinow, R. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.035 · Cited by 1,042
Luo, Y., Bolon, B., Kahn, S., Bennett, B. D., Babu-Khan, S., Denis, P., Fan, W., Kha, H., Zhang, J., Gong, Y., et al. (2001) · Nature Neuroscience · doi:10.1038/85059 · Cited by 1,001
Self-citationLong-term depression in the CNS
Collingridge, G. L., Peineau, S., Howland, J. G., & Wang, Y. T. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2867 · Cited by 926
Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit
Roche, K. W., O'Brien, R. J., Mammen, A. L., Bernhardt, J., & Huganir, R. L. (1996) · Neuron · doi:10.1016/s0896-6273(00)80144-0 · Cited by 812
Lee, H.-K., Takamiya, K., Han, J.-S., Man, H., Kim, C.-H., Rumbaugh, G., Yu, S., Ding, L., He, C., Petralia, R. S., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00122-3 · Cited by 802
The secretases: enzymes with therapeutic potential in Alzheimer disease
De Strooper, B., Vassar, R., & Golde, T. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.218 · Cited by 799
Self-citationElevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease
Yang, L.-B., Lindholm, K., Yan, R., Citron, M., Xia, W., Yang, X.-L., Beach, T., Sue, L., Wong, P., Price, D., et al. (2003) · Nature Medicine · doi:10.1038/nm0103-3 · Cited by 729
Self-citationThe genetics of Alzheimer disease
Tanzi, R. E. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006296 · Cited by 727
Regulatory mechanisms of AMPA receptors in synaptic plasticity
Derkach, V. A., Oh, M. C., Guire, E. S., & Soderling, T. R. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2055 · Cited by 708
Roberds, S. L. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.12.1317 · Cited by 705
Control of Peripheral Nerve Myelination by the ß-Secretase BACE1
Willem, M., Garratt, A. N., Novak, B., Citron, M., Kaufmann, S., Rittger, A., DeStrooper, B., Saftig, P., Birchmeier, C., & Haass, C. (2006) · Science · doi:10.1126/science.1132341 · Cited by 703 · cited 1×
“…previously identified BACE1 substrates such as neuregulin-1 (Nrg1) (Fleck et al., 2013; Hu et al., 2008; Hu et al., 2006; Luo et al., 2011; Willem et al., 2006), voltage-gated channel proteins such as sodium channel protein β-subunits (Kim et al., 2007; Kim et al., 2011; Wong et…”
Multimodal techniques for diagnosis and prognosis of Alzheimer's disease
Perrin, R. J., Fagan, A. M., & Holtzman, D. M. (2009) · Nature · doi:10.1038/nature08538 · Cited by 702 · cited 1×
“…studies that argue against the causative role of toxic Aβ in AD pathogenesis [i.e., no correlation of plaque density with severity of dementia (Perrin et al., 2009)] and the lack of patients diagnosed with amyloid plaque-only dementia (Benilova et al., 2012; Skaper, 2012), it is legitimate…”
Zempel, H., Thies, E., Mandelkow, E., & Mandelkow, E.-M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2357-10.2010 · Cited by 686 · cited 1×
“…2+ either in pre- or postsynaptic zones cause activation of calpain, which can lead to activation of cdk5 for Tau hyperphosphorylation and mis-sorting of endogenous Tau into dendrites, as well as pronounced depletion of microtubules and mitochondria (Frandemiche et al., 2014; Zempel et al., 2010).”
De Felice, F. G., Vieira, M. N. N., Bomfim, T. R., Decker, H., Velasco, P. T., Lambert, M. P., Viola, K. L., Zhao, W.-Q., Ferreira, S. T., & Klein, W. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809158106 · Cited by 657 · cited 1×
“Activation of insulin signaling, on the other hand, appears to downregulate binding of Aβ to NMDARs and thus blocks synaptic impairments (De Felice et al., 2009).”
Kuhn, P., Wang, H., Dislich, B., Colombo, A., Zeitschel, U., Ellwart, J. W., Kremmer, E., Roßner, S., & Lichtenthaler, S. F. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.167 · Cited by 621 · cited 1×
“ADAM10, as well as ADAM17 and ADAM9, are recognized as α-secretases and prevent Aβ formation by cleaving APP within the Aβ domain (mainly after Q16 and K17) [see reviews by (Allinson et al., 2004; Asai et al., 2003; Haass et al., 2012; Kuhn et al., 2010; Saftig and Lichtenthaler, 2015)].”
Lüscher, C., & Slesinger, P. A. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2834 · Cited by 617 · cited 1×
“Relatedly, deficiency or mutations in Girk channels, particularly the GIRK2 subunit, reduce LTP and increase LTD in hippocampus (Luscher and Slesinger, 2010).”
Bace1 modulates myelination in the central and peripheral nervous system
Hu, X., Hicks, C. W., He, W., Wong, P., Macklin, W. B., Trapp, B. D., & Yan, R. (2006) · Nature Neuroscience · doi:10.1038/nn1797 · Cited by 608 · cited 1×
“In addition to previously identified BACE1 substrates such as neuregulin-1 (Nrg1) (Fleck et al., 2013; Hu et al., 2008; Hu et al., 2006; Luo et al., 2011; Willem et al., 2006), voltage-gated channel proteins such as sodium channel protein β-subunits (Kim et al., 2007; Kim et al., 2011; Wong et…”
Self-citationAβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss
Talantova, M., Sanz-Blasco, S., Zhang, X., Xia, P., Akhtar, M. W., Okamoto, S.-I., Dziewczapolski, G., Nakamura, T., Cao, G., Pratt, A. E., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306832110 · Cited by 600
Regulation of AMPA receptor trafficking and synaptic plasticity
Anggono, V., & Huganir, R. L. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2011.12.006 · Cited by 588 · cited 1×
“Alternatively, clustering of Ca 2+ -sensitive CaMKII at synapses regulates AMPAR surface expression, while src/fyn kinase, PKC, and cdk5 also regulate trafficking of different AMPARs to control their activities (Anggono and Huganir, 2012; Wang et al., 2014).”
Increased expression of the amyloid precursor β‐secretase in Alzheimer's disease
Holsinger, R. M. D., McLean, C. A., Beyreuther, K., Masters, C. L., & Evin, G. (2002) · Annals of Neurology · doi:10.1002/ana.10208 · Cited by 562 · cited 1×
“Indeed, in AD brains, BACE1 levels are increased ~2-fold compared to healthy non-demented brains (Fukumoto et al., 2002; Holsinger et al., 2002; Li et al., 2004; Yang et al., 2003).”
Regulation of AMPA receptor lateral movements
Borgdorff, A. J., & Choquet, D. (2002) · Nature · doi:10.1038/nature00780 · Cited by 542 · cited 1×
“…AMPARs, but not NMDARs, into and out of the synaptic membrane, followed by internalization, induces long-term depression (LTD), which can in turn cause endocytosis of NMDARs, shrinkage of dendritic spines, endocytosis of AMPARs, and synapse loss (Borgdorff and Choquet, 2002; Lau and Zukin, 2007).”
Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5
Renner, M., Lacor, P. N., Velasco, P. T., Xu, J., Contractor, A., Klein, W. L., & Triller, A. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.029 · Cited by 468 · cited 1×
“If locally produced Aβ is accumulated and laterally forms Aβ oligomers, it will induce clustering of the postsynaptic GluR5 and elevation of intracellular Ca 2+ , thereby causing synapse reduction (Renner et al., 2010).”
Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein
Balducci, C., Beeg, M., Stravalaci, M., Bastone, A., Sclip, A., Biasini, E., Tapella, L., Colombo, L., Manzoni, C., Borsello, T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911829107 · Cited by 466 · cited 1×
“…to replicate the role of PrP in Aβ-induced synaptic depression, reduction in spine density, or blockade of LTP, regardless of whether PrP was overexpressed or ablated (Balducci et al., 2010; Calella et al., 2010; Kessels et al., 2010), arguing against a critical role of PrP as a coupling receptor.”
Wang, Q., Walsh, D. M., Rowan, M. J., Selkoe, D. J., & Anwyl, R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1633-03.2004 · Cited by 437
Synapses and Alzheimer's Disease
Sheng, M., Sabatini, B. L., & Sudhof, T. C. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005777 · Cited by 436
η-Secretase processing of APP inhibits neuronal activity in the hippocampus
Willem, M., Tahirovic, S., Busche, M. A., Ovsepian, S. V., Chafai, M., Kootar, S., Hornburg, D., Evans, L. D. B., Moore, S., Daria, A., et al. (2015) · Nature · doi:10.1038/nature14864 · Cited by 398 · cited 4×
“, who refer this cleavage as η-secretase, which possesses membrane-bound matrix metalloproteinase activity and cleaves APP695 between residues 504-505 (Willem et al., 2015).”
InfluentialBeta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses
Almeida, C. G., Tampellini, D., Takahashi, R. H., Greengard, P., Lin, M. T., Snyder, E. M., & Gouras, G. K. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.02.008 · Cited by 397
ORGANELLES AND TRAFFICKING MACHINERY FOR POSTSYNAPTIC PLASTICITY
Kennedy, M. J., & Ehlers, M. D. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.112808 · Cited by 346
Depletion of GGA3 Stabilizes BACE and Enhances β-Secretase Activity
Tesco, G., Koh, Y. H., Kang, E. L., Cameron, A. N., Das, S., Sena-Esteves, M., Hiltunen, M., Yang, S.-H., Zhong, Z., Shen, Y., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.05.012 · Cited by 337 · cited 4×
“proteins can bind BACE1 via the di-leucine motif and impact not only its endosomal trafficking, but also its stability (He et al., 2002; He et al., 2005; Santosa et al., 2011; Tesco et al., 2007; von et al., 2015; Wahle et al., 2005; Walker et al., 2012).”
InfluentialBenjannet, S., Elagoz, A., Wickham, L., Mamarbachi, M., Munzer, J. S., Basak, A., Lazure, C., Cromlish, J. A., Sisodia, S., Checler, F., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009899200 · Cited by 301 · cited 1×
“In the Golgi, BACE1 deacetylation (Costantini et al., 2007) and palmitoylation in four C-terminal Cys residues (Cys474/478/482/485) for lipid raft localization (Benjannet et al., 2001; Bhattacharyya et al., 2013; Vetrivel et al., 2009) occur.”
McConlogue, L., Buttini, M., Anderson, J. P., Brigham, E. F., Chen, K. S., Freedman, S. B., Games, D., Johnson-Wood, K., Lee, M., Zeller, M., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611687200 · Cited by 300 · cited 1×
“In BACE1-null mice, Aβ generation is almost abolished, and significant reductions in Aβ are seen in BACE1 heterozygous mice (McConlogue et al., 2007).”
Sannerud, R., Declerck, I., Peric, A., Raemaekers, T., Menendez, G., Zhou, L., Veerle, B., Coen, K., Munck, S., De Strooper, B., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100745108 · Cited by 286
Das, U., Scott, D. A., Ganguly, A., Koo, E. H., Tang, Y., & Roy, S. (2013) · Neuron · doi:10.1016/j.neuron.2013.05.035 · Cited by 282
Lessons from a failed γ-secretase Alzheimer trial
De Strooper, B. (2014) · Cell · doi:10.1016/j.cell.2014.10.016 · Cited by 277
Frandemiche, M. L., De Seranno, S., Rush, T., Borel, E., Elie, A., Arnal, I., Lanté, F., & Buisson, A. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.4261-13.2014 · Cited by 272 · cited 1×
“…2+ either in pre- or postsynaptic zones cause activation of calpain, which can lead to activation of cdk5 for Tau hyperphosphorylation and mis-sorting of endogenous Tau into dendrites, as well as pronounced depletion of microtubules and mitochondria (Frandemiche et al., 2014; Zempel et al., 2010).”
VPS35 haploinsufficiency increases Alzheimer’s disease neuropathology
Wen, L., Tang, F.-L., Hong, Y., Luo, S.-W., Wang, C.-L., He, W., Shen, C., Jung, J.-U., Xiong, F., Lee, D.-H., et al. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201105109 · Cited by 270
Self-citationModels of β-amyloid induced Tau-pathology: The long and “folded” road to understand the mechanism
Stancu, I.-C., Vasconcelos, B., Terwel, D., & Dewachter, I. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-51 · Cited by 256
The prion protein as a receptor for amyloid-β
Kessels, H. W., Nguyen, L. N., Nabavi, S., & Malinow, R. (2010) · Nature · doi:10.1038/nature09217 · Cited by 253 · cited 1×
“…to replicate the role of PrP in Aβ-induced synaptic depression, reduction in spine density, or blockade of LTP, regardless of whether PrP was overexpressed or ablated (Balducci et al., 2010; Calella et al., 2010; Kessels et al., 2010), arguing against a critical role of PrP as a coupling receptor.”
Smith, W. B., Starck, S. R., Roberts, R. W., & Schuman, E. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.015 · Cited by 252 · cited 2×
“It has been shown that D1R activation can lead to an increase in surface expression of AMPA and NMDA receptors by modulating NMDAR-dependent synaptic plasticity (Gao and Wolf, 2007; Gao and Wolf, 2008; Smith et al., 2005).”
Prion protein and Aβ‐related synaptic toxicity impairment
Calella, A. M., Farinelli, M., Nuvolone, M., Mirante, O., Moos, R., Falsig, J., Mansuy, I. M., & Aguzzi, A. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000082 · Cited by 242 · cited 1×
“…to replicate the role of PrP in Aβ-induced synaptic depression, reduction in spine density, or blockade of LTP, regardless of whether PrP was overexpressed or ablated (Balducci et al., 2010; Calella et al., 2010; Kessels et al., 2010), arguing against a critical role of PrP as a coupling receptor.”
Axonal BACE1 dynamics and targeting in hippocampal neurons: a role for Rab11 GTPase
Buggia-Prévot, V., Fernandez, C. G., Riordan, S., Vetrivel, K. S., Roseman, J., Waters, J., Bindokas, V. P., Vassar, R., & Thinakaran, G. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-1 · Cited by 214
Self-citationImmunotherapy for Alzheimer’s disease: hoops and hurdles
Lemere, C. A. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-36 · Cited by 196
Rammes, G., Hasenjäger, A., Sroka-Saidi, K., Deussing, J. M., & Parsons, C. G. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.051 · Cited by 163 · cited 1×
“By weak low-frequency stimulation, oligomeric Aβ can bind to mGluR1/5 to induce Aβ-mediated synaptic depression (promoting LTD) and blockage of LTP (Chen et al., 2013; Kessels et al., 2013; Rammes et al., 2011; Wang et al., 2004).”
Vetrivel, K. S., Meckler, X., Chen, Y., Nguyen, P. D., Seidah, N. G., Vassar, R., Wong, P. C., Fukata, M., Kounnas, M. Z., & Thinakaran, G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808920200 · Cited by 153 · cited 1×
“It has been shown that hippocampal Aβ injections in rat are sufficient to induce reductions in GABAergic input to the hippocampus and to exhibit aberrant θ 24 oscillations (Villette et al., 2010).”
Self-citationA Physiological Role for Amyloid-β Protein: Enhancement of Learning and Memory
Morley, J. E., Farr, S. A., Banks, W. A., Johnson, S. N., Yamada, K. A., & Xu, L. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1230 · Cited by 141 · cited 1×
“Rodent hippocampal slice recording experiments also show that Aβ₄₂ facilitates induction and maintenance of long term potentiation, whereas treatment with Aβ antibodies inhibits hippocampal LTP (Morley et al., 2010).”
Guzmán-Ramos, K., Moreno-Castilla, P., Castro-Cruz, M., McGaugh, J. L., Martínez-Coria, H., LaFerla, F. M., & Bermúdez-Rattoni, F. (2012) · Learning & Memory · doi:10.1101/lm.026070.112 · Cited by 127 · cited 1×
“Strikingly, AD mouse models treated with either the dopamine precursor levodopa (Ambree et al., 2009), the dopamine reuptake blocker nomifensine (Guzman-Ramos et al., 2012), or even the dopamine receptor agonist apomorphine (Himeno et al., 2011) showed rescued Aβ- mediated impairments in memory and…”
Levodopa ameliorates learning and memory deficits in a murine model of Alzheimer’s disease
Ambrée, O., Richter, H., Sachser, N., Lewejohann, L., Dere, E., de Souza Silva, M. A., Herring, A., Keyvani, K., Paulus, W., & Schäbitz, W.-R. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.010 · Cited by 115
Hitt, B. D., Jaramillo, T. C., Chetkovich, D. M., & Vassar, R. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-31 · Cited by 99 · cited 2×
“, 2005), the potassium channel proteins KCNE1 and 2 (Hitt et al., 2010; Sachse et al., 2013), neural cell adhesion molecule close homolog of L1 (Hitt et al.”
Self-citationBaglietto-Vargas, D., Moreno-Gonzalez, I., Sanchez-Varo, R., Jimenez, S., Trujillo-Estrada, L., Sanchez-Mejias, E., Torres, M., Romero-Acebal, M., Ruano, D., Vizuete, M., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100066 · Cited by 98 · cited 2×
“Intriguingly, others have failed to replicate the role of PrP in Aβ-induced synaptic depression, reduction in spine density, or blockade of LTP, regardless of whether PrP was overexpressed or ablated (Balducci et al., 2010; Calella et al., 2010; Kessels et al., 2010), arguing against a critical role of PrP as a coupli…”
LTP and LTD in cortical GABAergic interneurons: Emerging rules and roles
Kullmann, D. M., & Lamsa, K. P. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.12.020 · Cited by 96 · cited 1×
“In adult brain, GABAergic synapses are mainly inhibitory synapses, which are typically formed either on soma or dendrites from neurons classified as inhibitory interneurons (Freund and Katona, 2007; Fritschy et al., 2012; Kullmann and Lamsa, 2011).”
Chen, X., Lin, R., Chang, L., Xu, S., Wei, X., Zhang, J., Wang, C., Anwyl, R., & Wang, Q. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.08.054 · Cited by 93 · cited 1×
“By weak low-frequency stimulation, oligomeric Aβ can bind to mGluR1/5 to induce Aβ-mediated synaptic depression (promoting LTD) and blockage of LTP (Chen et al., 2013; Kessels et al., 2013; Rammes et al., 2011; Wang et al., 2004).”
Jürgensen, S., Antonio, L. L., Mussi, G. E. A., Brito-Moreira, J., Bomfim, T. R., De Felice, F. G., Garrido-Sanabria, E. R., Cavalheiro, É. A., & Ferreira, S. T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.177790 · Cited by 88
Buggia-Prévot, V., Fernandez, C. G., Udayar, V., Vetrivel, K. S., Elie, A., Roseman, J., Sasse, V. A., Lefkow, M., Meckler, X., Bhattacharyya, S., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.12.006 · Cited by 77 · cited 1×
“…can be regulated by altered levels of calsyntenin-1 (Steuble et al., 2012; Vagnoni et al., 2012), retromer vps35 (Wang et al., 2012a; Wen et al., 2011), RTN3 (Deng et al., 2013), Rab11, and Eps15 homology domain proteins (Buggia-Prevot et al., 2014; Buggia-Prevot et al., 2013; Udayar et al., 2013).”
Self-citationDepletion of GGA1 and GGA3 Mediates Postinjury Elevation of BACE1
Walker, K. R., Kang, E. L., Whalen, M. J., Shen, Y., & Tesco, G. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5491-11.2012 · Cited by 66 · cited 1×
“…ribosylation factor-binding (GGA) family proteins can bind BACE1 via the di-leucine motif and impact not only its endosomal trafficking, but also its stability (He et al., 2002; He et al., 2005; Santosa et al., 2011; Tesco et al., 2007; von et al., 2015; Wahle et al., 2005; Walker et al., 2012).”
Loss of Dopamine Uptake Sites Labeled with [ 3 H]GBR-12935 in Alzheimer’s Disease
Allard, P., Alafuzoff, I., Carlsson, A., Eriksson, K., Ericson, E., Gottfries, C.-G., & Marcusson, J. O. (2008) · European Neurology · doi:10.1159/000117341 · Cited by 64 · cited 1×
“…due to dramatically reduced expressions of both D1R and D2R, as well as DAT and TH, are found mainly in prefrontal cortex and hippocampus (Allard et al., 1990; Cross et al., 1984; Joyce et al., 1998; Kemppainen et al., 2003; Kumar and Patel, 2007; Murray et al., 1995; Rinne et al.,…”
Sorting nexin 12 interacts with BACE1 and regulates BACE1-mediated APP processing
Zhao, Y., Wang, Y., Yang, J., Wang, X., Zhao, Y., Zhang, X., & Zhang, Y.-W. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-30 · Cited by 63
Kang, E. L., Biscaro, B., Piazza, F., & Tesco, G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.407072 · Cited by 55
Differential Release of β-Amyloid from Dendrite- Versus Axon-Targeted APP
DeBoer, S. R., Dolios, G., Wang, R., & Sisodia, S. S. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2255-14.2014 · Cited by 51
Cited by
Jadiya, P., Kolmetzky, D. W., Tomar, D., Di Meco, A., Lombardi, A. A., Lambert, J. P., Luongo, T. S., Ludtmann, M. H., Praticò, D., & Elrod, J. W. (2019) · Nature Communications · doi:10.1038/s41467-019-11813-6 · Cited by 323
The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease
Neumann, U., Ufer, M., Jacobson, L. H., Rouzade‐Dominguez, M., Huledal, G., Kolly, C., Lüönd, R. M., Machauer, R., Veenstra, S. J., Hurth, K., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201809316 · Cited by 177
“…compounds has emerged as a new concept for treatment of AD (Vassar et al, 2014; Eketjall et al, 2016; Kennedy et al, 2016; Timmers et al, 2016, 2017; Yan et al, 2016; Cebers et al, 2017) by preventing the generation and deposition of Ab rather than just treating the dementia symptoms.”
Background3D culture models of Alzheimer’s disease: a road map to a “cure-in-a-dish”
Choi, S. H., Kim, Y. H., Quinti, L., Tanzi, R. E., & Kim, D. Y. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0139-7 · Cited by 132
Kimura, A., Hata, S., & Suzuki, T. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.744722 · Cited by 95
Qu, J., Xiong, X., Hujie, G., Ren, J., Yan, L., & Ma, L. (2021) · Cell Cycle · doi:10.1080/15384101.2021.1982507 · Cited by 30
Metadata
- Authors
- Yan, R., Fan, Q., Zhou, J., & Vassar, R.
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2016-06
- Volume
- 65
- Pages
- 326-340
- ISSN
- 0149-7634 (ISSN-L)
- OpenAlex
- W2317591111
- Cited by
- 71
- References
- 75
- FWCI
- 7.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.